2016 05 Mar
Over the past 25 years, gadolinium-based contrast agents (GBCA) have been recognised to have exceptional safety profiles with minimal side effects, as three researchers showed in their presentations at the European Congress of Radiology (ECR 2016) in Vienna. Dr. Richard Semelka of the Department of Radiology, University of North Carolina... Read more
JOIN OUR MANAGEMENT COMMUNITY
Masimo announces FDA clearance of the rainbow acoustic monitoring® RAS-45 sensor
Masimo announced today FDA clearance of RAS-45, an acoustic respiration... Read more
Samsung showcases advanced ultrasound solutions at EUROSON 2018
Highlighting RS85, the latest premium ultrasound solution with superb... Read more
SCHILLER launches the ECG device CARDIOVIT AT-102 G2
SCHILLER’s latest ECG device CARDIOVIT AT-102 G2 has been launched.... Read more
Healthio designs specific itinerary on cancer offering a wide range of information
Several leading medical centres, together with start-up companies,... Read more
HEALTHIO will present the best experiences in health through themed itineraries
The second edition of HEALTHIO is already taking shape. With five months... Read more
Dr. Arthur Kanowitz Appointed Chairman of Patient Safety Movement Foundation
Arthur Kanowitz, MD appointed Chairman of the Airway Safety Taskforce... Read more
HANJ Recognizes CSL CEO Paul Perreault as “Humanitarian Man of the Year”
HANJ President David Lechner presented the award to Perreault at the... Read more
Geraldine McGinty to Receive Thorwarth Award for Radiology Leadership
The American College of Radiology selected Geraldine McGinty ,... Read more
John Ormiston Awarded the EuroPCR 2017 Ethica Award
The 2017 Ethica Award, the highest honour of the European cardiovascular... Read more
New President of Sectra’s Secure Communications Business Area
Simo Pykälistö, currently CFO and Executive Vice President of Sectra... Read more
JOIN OUR MANAGEMENT COMMUNITY
JOIN OUR MANAGEMENT COMMUNITY